Jensyn Acquisition Corp. Announces Agreement for Business

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
67
Jensyn Acquisition Corp. Announces Agreement for Business Combination with HEFA Global

Freehold, N.J, Aug. 15, 2018 (GLOBE NEWSWIRE) -- Jensyn Acquisition Corp. (NASDAQ: JSYN ) (“Jensyn” or the “Company”) , a company formed for the purpose of entering into a merger, share exchange, asset acquisition or other similar business combination with one or more businesses or entities, today announced that it has signed a definitive agreement to enter into a business combination with Oneness Global, an e-commerce company based in China that operates under the name “HEFA Global.”

At the closing of the business combination, the stockholders of HEFA Global will exchange their shares in HEFA Global for shares of Jensyn common stock representing approximately 85% of Jensyn’s outstanding shares after giving effect to the business combination, subject to adjustment based upon, among other things, HEFA Global’s net cash and net working capital, the amount of Jensyn transaction expenses paid by HEFA, the number of shares of Jensyn common stock issued in satisfaction of certain obligations and the amount paid by Jensyn from its trust account to pay expenses.

The closing of the business combination is subject to a number of conditions, including the approval of Jensyn’s stockholders.

The senior management of HEFA Global will replace Jensyn’s existing management team following the closing of the business combination.

About HEFA Global

HEFA Global is an e-commerce company based in China that has developed a "shared and collaborative commerce" platform with a focus on wellness, health and beauty products and hotel booking and shared rentals. HEFAs Global’s mobile platform offers a comprehensive selection of attractively priced merchandise and features a dynamic social shopping experience that leverages social networks as an effective and efficient tool for buyer and merchant acquisition and engagement in an eco-system. Its business model enables its Registered Merchant (RM) networks to become powerful distribution channels for its products and services through their direct sales and social media networks. As a result of its innovative business model, HEFA Global has been able to quickly expand its buyer base and establish brand recognition and market position.

HEFA Global has pioneered an innovative "shared and collaborative commerce" model whereby consumers create product demands to the manufacturers on the HEFA Global platform. Consumers are encouraged to share product information on such social networks, and invite their friends, family and social contacts to join HEFA Global’s "shared and collaborative commerce" platform and register RM merchants. Buyers and merchants on the platform actively introduce HEFA Global to, and share products offered on the platform and their shopping experiences with, their friends, family and social contacts. New buyers and merchants in turn refer the HEFA Global platform to their broader family and social networks, generating low-cost organic traffic and active interactions and leading to exponential growth of HEFA Global’s buyer and merchant base. HEFA Global has developed its own proprietary technology infrastructure that seamlessly connects its platform with buyers and merchants and supports its business growth.

About Jensyn Acquisition Corp.

Jensyn Acquisition Corp. is a blank check company formed for the purpose of entering into a merger, share exchange, asset acquisition, stock purchase, recapitalization, reorganization or other similar business combination with one or more businesses or entities.

Forward-Looking Statements

This press release includes “forward-looking statements” within the meaning of the “safe harbor” provisions of the United Stated Private Securities Litigation Reform Act of 1995. Forward-looking statements are not historical facts, and involve risks and uncertainties that could cause actual results to differ materially from those expected and projected. Words such as “expects”, “believes”, “anticipates”, “intends”, “estimates”, “seeks” and variations and similar words and expressions are intended to identify such forward-looking statements. Such forward-looking statements with respect to revenues, earnings, performance, strategies, prospects and other aspects of the businesses of Jensyn, HEFA Global and the combined company after completion of the proposed business combination, are based on current expectations that are subject to risks and uncertainties. A number of factors could cause actual events, performance or results to differ materially from the events, performance and results discussed in the forward-looking statements. These factors include, but are not limited to: (1) the occurrence of any event, change or other circumstances that could give rise to the termination of the business combination agreement relating to the proposed business combination; (2) the outcome of any legal proceedings that may be instituted against Jensyn, HEFA Global or others following announcement of the business combination agreement and transactions contemplated therein; (3) the inability to complete the transactions contemplated by the business combination agreement due to the failure to obtain approval of the stockholders of Jensyn or other conditions to closing in the business combination agreement; (4) delays in obtaining, adverse conditions contained in, or the inability to obtain necessary regulatory approvals or complete regulatory reviews required to complete the transactions contemplated by the business combination agreement; (5) the risk that the proposed transaction disrupts current plans and operations as a result of the announcement and consummation of the transactions described herein; (6) the ability to recognize the anticipated benefits of the proposed business combination, which may be affected by, among other things, competition, the ability of the combined company to grow and manage growth profitably, maintain relationships with suppliers and obtain adequate supply of products and retain its key employees; (7) costs related to the proposed business combination; (8) changes in applicable laws or regulations; (9) the possibility that the combined company may be adversely affected by other economic, business, and/or competitive factors and not achieve projected results; and (10) other risks and uncertainties indicated from time to time in the proxy statements relating to the proposed business combination, including those under “Risk Factors” therein, and other filings with the United States Securities and Exchange Commission (“SEC”) by Jensyn. Readers are cautioned not to place undue reliance upon any forward-looking statements, which speak only as of the date made, and Jensyn and HEFA Global undertake no obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise.

Additional Information about the Business Combination and Where to Find It

In connection with the proposed business combination, Jensyn intends to file with the SEC a preliminary proxy statement. When completed, Jensyn will mail a definitive proxy statement and other relevant documents to its stockholders in connection with its solicitation of proxies for the special meeting of stockholders to be held to approve the proposed business combination and related transactions. This press release does not contain all the information that should be considered concerning the proposed business combination. It is not intended to provide the basis for any investment decision or any other decision in respect to the proposed business combination. Jensyn stockholders and other interested persons are advised to read, when available, the preliminary proxy statement, the amendments thereto, and the definitive proxy statement in connection with Jensyn’s solicitation of proxies for the special meeting to be held to approve the proposed business combination, as these materials will contain important information about HEFA Global, Jensyn and the proposed business combination. The definitive proxy statement will be mailed to stockholders of Jensyn as of a record date to be established for voting on the business combination agreement and related transactions. Stockholders will also be able to obtain copies of the proxy statement, without charge, once available, at the SEC’s Internet site at http://www.sec.gov , or by directing a request to: Jensyn Acquisition Corp., 800 West Main Street, Suite 204, Freehold, New Jersey 07728, attention: Jeffrey J. Raymond, 1-888-536-7965.

Jensyn and its directors and executive officers and HEFA Global and its stockholders and executive officers may be deemed to be participants in the solicitation of proxies from the stockholders of Jensyn in connection with the proposed business combination. Information regarding the special interests of these directors, members and executive officers in the business combination will be included in the proxy statement referred to above. Additional information regarding the directors and executive officers of Jensyn is also included in the Annual Report on Form 10-K for the year ended December 31, 2017, which is available free of charge at the SEC web site ( www.sec.gov ) and at the address described above and will also be contained in the definitive proxy statement for the proposed business combination) when available.

Contact: Jeffrey Raymond President and Chief Executive Officer Jensyn Acquisition Corp. +1 (888) 536-7965 jeff.raymond@jensyn.com www.jensyn.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Fuse Oncology Showcases New iRT Workflow at ASTRO

Updated Category News Views 3

Revolutionizing Charge Capture in Oncology Fuse Oncology's latest showcase at the ASTRO 2026 Annual Meeting isn't just about flashy presentations—it's looking to change how radiation oncology departments handle complex workflows. If you've ever delved into the maze of oncology billing, you know it's rife with opportunities for errors and inefficiencies. Skip one charge,...

Continue Reading
Synagro Technologies Faces Lawsuit Over Unpaid Expenses

Updated Category News Views 4

Another Day, Another Lawsuit in Corporate America When it rains, it pours, especially in the corporate world where companies occasionally seem to forget they're playing with other people's livelihoods. Now, it's Synagro Technologies, Inc. facing the music. The company is under fire from Blumenthal Nordrehaug Bhowmik De Blouw LLP, a law firm well-versed in employee rights...

Continue Reading
Cut Winter Heating Costs with Townsend's Rebate Help

Updated Category News Views 9

Unseen Perils of Winter Heating in Massachusetts Massachusetts homeowners, listen up. If your heating system is older than the Model T, it's time to rethink your winter strategy. You don't want to be stuck in the cold when the thermometer hits single digits, do you? That's where Townsend comes in, making waves with their rebate assistance program. Navigating the Rebate...

Continue Reading
IASO's FUCASO Shows Robust Results in 2026 Study

Updated Category News Views 5

IASO's Groundbreaking Results Stir Ripples in Oncology Folks, let me paint the picture here with the mighty, nitty-gritty details straight from the heart of China. The 2026 IMS Annual Meeting held a gem that could redefine how investors see the course of hematologic malignancy treatments. IASO Bio dropped some heavy data, showing their fine product, FUCASO, in a...

Continue Reading
Quay Shines in 2026 Prescription Sunglasses Lineup

Updated Category News Views 4

Spotlight on Quay: A Fashion-Forward Prescription Glasses that make you look good and actually correct your vision? That's the holy grail right there. Consumer365 just put Quay front and center in their 2026 rundown of the best prescription sunglasses out there. Let's break this down and see what's got folks buzzing. Diving into Style and Substance Now, if you're like me,...

Continue Reading
China Southern Airlines Marks 70th Anniversary in NYC

Updated Category News Views 4

Taking Flight with Legacy and Tradition Throwing a bash on Times Square isn't just about flash; it's about letting folks know you mean business. And China Southern Airlines has been doing just that for 70 years. Imagine starting from Guangzhou and ending up splashed across New York City's giant LED screens—talk about a journey! From Humble Roots to Global Network...

Continue Reading
Endurance Energy's Modular Tech Revs Up Southeast Asia

Updated Category News Views 4

Modular Solutions Steal the Show in Bangkok When a company draws 59,468 attendees from over 150 countries, folks pay attention—and that was exactly the scene at Gastech 2026 in Bangkok. The name buzzing on many lips? Endurance Energy. These guys showcased a fresh take on energy logistics with their skid-mounted liquefaction tech, turning heads with their Southeast Asia...

Continue Reading
AST SpaceMobile Faces Class Action Over Misstatements

Updated Category News Views 4

What's Going On with AST SpaceMobile? Kicking off with a heavy hitter here, folks. AST SpaceMobile, Inc., trading under NASDAQ:ASTS, is under a securities fraud spotlight. We're talking allegations piled higher than a morning stack of pancakes. If you picked up any ASTS shares between March 4, 2025, and July 15, 2026, you're in on this rough ride. There's a class action...

Continue Reading
Farm Aid 2026: A Resilient Tribute to Family Farmers

Updated Category News Views 8

Shining a Light on Essential Family Farmers Every year, thousands gather for Farm Aid to back the unsung heroes who put food on our plates. In 2026, the scene shifted to the amphitheater at Virginia Beach, where an epic lineup of music took stage not just to entertain but to underline a critical issue—family farmers are fighting for survival. These folks aren't merely...

Continue Reading
Leo Cancer Care's Upright Radiotherapy Milestone

Updated Category News Views 3

Upright Radiotherapy: Breaking Tradition in Cancer Care Here's a twist in the world of cancer treatment folks weren't exactly expecting. Leo Cancer Care has flipped the script by taking radiotherapy from a concept to an actual clinical reality with their Upright Platform. Yes, we're talking about standing up while getting treated, and it's not just a gimmick—it's a game...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Imaging Techniques for Lung Cancer Treatment Success

Updated Category News Views 37

Revolutionary Techniques in Lung Cancer Management Onc.AI, a leading digital health innovator, is making strides in oncology clinical management with its pioneering approach toward imaging in advanced non-small cell lung cancer (NSCLC). The company focuses on integrating artificial intelligence into healthcare to enhance patient survival rates in cancer treatments....

Continue Reading
Kane Biotech Secures Funding Through Private Placement Initiative

Updated Category News Views 173

Kane Biotech Achieves Significant Milestone with Recent Funding Kane Biotech Inc. has recently made headlines by completing the first closing of its exciting non-brokered private placement offering. This strategic move is set to enhance the company’s capacity to innovate and expand its market presence. Private Placement Offering Details Under this newly announced...

Continue Reading
Apple Adjusts iPhone Air Production Amidst Strong Demand Shift

Updated Category News Views 183

Apple's Strategic Shift in iPhone Production Apple Inc. (NASDAQ:AAPL) has made a significant decision to decrease production orders for its iPhone Air while ramping up production for other flagship models like the iPhone 17. This change comes amid a surge in demand for these devices, particularly in markets that are seeing stronger consumer engagement. Weak Demand Impacts...

Continue Reading
Navigating Legal Proceedings: Insights for RxSight Investors

Updated Category News Views 273

A Comprehensive Guide for RxSight Investors Amid Legal Concerns Investors in RxSight, Inc. should be aware of the growing legal challenges facing the company. Robbins Geller Rudman & Dowd LLP is leading a class action lawsuit aimed at representing those who have faced significant financial losses while investing in RxSight (NASDAQ: RXST). This article delves into the...

Continue Reading
Reusable Laryngoscope System Market Growth Projections for 2034

Updated Category News Views 120

Tremendous Growth in the Reusable Laryngoscope System Market The reusable laryngoscope system market is on track for significant expansion, currently valued at around $920 million in the near term. With the healthcare industry increasingly leaning towards efficient and cost-effective solutions, this market is projected to reach approximately $1.8 billion by the year 2034....

Continue Reading